Pires, R. H., Saraiva, M. J., Damas, A. M., & Kellermayer, M. S. Z. (2017). Force spectroscopy reveals the presence of structurally modified dimers in transthyretin amyloid annular oligomers. Journal of Molecular Recognition, 30(3).

Ferreira, C., Rocha, F. A., Damas, A. M., & Martins, P. M. (2013). On growth rate hysteresis and catastrophic crystal growth. Journal of Crystal Growth.

Pires, R. H., Karsai, Á., Saraiva, M. J., Damas, A. M., & Kellermayer, M. S. Z. (2012). Distinct Annular Oligomers Captured along the Assembly and Disassembly Pathways of Transthyretin Amyloid Protofibrils. PLoS ONE, 7(9).

Crespo, R., Rocha, F. A., Damas, A. M., & Martins, P. M. (2012). A generic crystallization-like model that describes the kinetics of amyloid fibril formation. Journal of Biological Chemistry, 287(36), 30585 - 30594.

Liz, M. A., Leite, S. C., Juliano, L., Saraiva, M. J., et al. (2012). Transthyretin is a metallopeptidase with an inducible active site. Biochemical Journal, 443(3), 769 - 778.

Noborna, F., O'Callaghan, P., Hermansson, E., Zhang, X., et al. (2011). Heparan sulfate/heparin promotes transthyretin fibrillization through selective binding to a basic motif in the protein. Proceedings of the National Academy of Sciences of the United States of America, 108(14), 5584 - 5589.

Neves, M. P., Cidade, H., Pinto, M., Silva, A. M. S., et al. (2011). Prenylated derivatives of baicalein and 3,7-dihydroxyflavone: Synthesis and study of their effects on tumor cell lines growth, cell cycle and apoptosis. European Journal of Medicinal Chemistry, 46(6), 2562 - 2574.

Ferreira, C., Crespo, R., Martins, P. M., Gales, L., et al. (2011). Small temperature oscillations promote protein crystallization. CrystEngComm, 13(8), 3051 - 3056.

Sárkány, Z., Ikonen, T. P., Ferreira-Da-Silva, F., Saraiva, M. J., et al. (2011). Solution structure of the soluble receptor for advanced glycation end products (sRAGE). Journal of Biological Chemistry, 286(43), 37525 - 37534.

Castro-Rodrigues, A. F., Gales, L., Saraiva, M. J., & Damas, A. M. (2011). Structural insights into a zinc-dependent pathway leading to Leu55Pro transthyretin amyloid fibrils. Acta Crystallographica Section D: Biological Crystallography, 67(12), 1035 - 1044.

Pires, R. H., Saraiva, M. J., Damas, A. M., & Kellermayer, M. S. Z. (2011). Structure and assembly-disassembly properties of wild-type transthyretin amyloid protofibrils observed with atomic force microscopy. Journal of Molecular Recognition, 24(3), 467 - 476.

Martins, P. M., Rocha, F., Damas, A. M., & Rein, P. (2011). Unsteady-state inhibition of crystal growth caused by solution impurities. CrystEngComm, 13(4), 1103 - 1110.

Afonso, R. V., Durão, J., Mendes, A., Damas, A. M., & Gales, L. (2010). Dipeptide crystals as excellent permselective materials: Sequential exclusion of argon, nitrogen, and oxygen. Angewandte Chemie - International Edition, 49(17), 3034 - 3036.

Freitas, V. L. S., Gomes, J. R. B., Gales, L., Damas, A. M., & Ribeiro Da Silva, M. D. M. C. (2010). Experimental and computational studies on the structural and thermodynamic properties of two sulfur heterocyclic keto compounds. Journal of Chemical and Engineering Data, 55(11), 5009 - 5017.

Fraga, H., Faria, T. Q., Pinto, F., Almeida, A., et al. (2010). FH8 - A small EF-hand protein from Fasciola hepatica. FEBS Journal, 277(24), 5072 - 5085.

Pessoa, J., Sárkány, Z., Ferreira-Da-Silva, F., Martins, S., et al. (2010). Functional characterization of Arabidopsis thaliana transthyretin-like protein. BMC Plant Biology, 10.

Crespo, R., Martins, P. M., Gales, L., Rocha, F., & Damas, A. M. (2010). Potential use of ultrasound to promote protein crystallization. Journal of Applied Crystallography, 43(6), 1419 - 1425.

Gales, L., Castanheiro, R. A. P., Pinto, M. M. M., & Damas, A. M. (2009). 1-Hydr-oxy-3-(3-methyl-but-2-en-yloxy)xanthone. Acta Crystallographica Section E: Structure Reports Online, 65(11), o2718 - o2719.

Sousa, E., Paiva, A., Nazareth, N., Gales, L., et al. (2009). Bromoalkoxyxanthones as promising antitumor agents: Synthesis, crystal structure and effect on human tumor cell lines. European Journal of Medicinal Chemistry, 44(9), 3830 - 3835.

Mairal, T., Nieto, J., Pinto, M., Almeida, M. R., et al. (2009). Iodine atoms: a new molecular feature for the design of potent transthyretin fibrillogenesis inhibitors. PLoS ONE, 4(1).

Mairal, T., Nieto, J., Pinto, M., Almeida, M. R., et al. (2009). Iodine atoms: A new molecular feature for the design of potent transthyretin fibrillogenesis inhibitors. PLoS ONE, 4(1).

Martins, P. M., Ferreira, A., Polanco, S., Rocha, F., et al. (2009). Unsteady-state transfer of impurities during crystal growth of sucrose in sugarcane solutions. Journal of Crystal Growth, 311(15), 3841 - 3848.

Gales, L., Almeida, M. R., Arsequell, G., Valencia, G., et al. (2008). Iodination of salicylic acid improves its binding to transthyretin. Biochimica et Biophysica Acta - Proteins and Proteomics, 1784(3), 512 - 517.

Martins, P. M., Pessoa, J., Sàrkàny, Z., Rocha, F., & Damas, A. M. (2008). Rationalizing protein crystallization screenings through water equilibration theory and protein solubility data. Crystal Growth and Design, 8(12), 4233 - 4243.

Martins, P. M., Rocha, F., & Damas, A. M. (2008). Understanding water equilibration fundamentals as a step for rational protein crystallization. PLoS ONE, 3(4).

Castanheiro, R. A. P., Pinto, M. M. M., Silva, A. M. S., Cravo, S. M. M., et al. (2007). Dihydroxyxanthones prenylated derivatives: Synthesis, structure elucidation, and growth inhibitory activity on human tumor cell lines with improvement of selectivity for MCF-7. Bioorganic and Medicinal Chemistry, 15(18), 6080 - 6088.

Gomes, J. R. B., Sousa, E. A., Gonçalves, J. M., Gales, L., et al. (2007). Energetic and structural characterization of 2-R-3-methylquinoxaline-1,4- dioxides (R = benzoyl or tert-butoxycarbonyl): Experimental and computational studies. Journal of Physical Organic Chemistry, 20(7), 491 - 498.

Dethoup, T., Manoch, L., Kijjoa, A., Pinto, M., et al. (2007). Merodrimanes and other constituents from Talaromyces thailandiasis. Journal of Natural Products, 70(7), 1200 - 1202.

Gales, L., Saraiva, M. J., & Damas, A. M. (2007). Structural basis for the protective role of sulfite against transthyretin amyloid formation. Biochimica et Biophysica Acta - Proteins and Proteomics, 1774(1), 59 - 64.

Morais-De-Sá, E., Neto-Silva, R. M., Pereira, P. J. B., Saraiva, M. J., & Damas, A. M. (2006). The binding of 2,4-dinitrophenol to wild-type and amyloidogenic transthyretin. Acta Crystallographica Section D: Biological Crystallography, 62(5), 512 - 519.

Ferreira-Da-Silva, F., Pereira, P. J. B., Gales, L., Roessle, M., et al. (2006). The crystal and solution structures of glyceraldehyde-3-phosphate dehydrogenase reveal different quaternary structures. Journal of Biological Chemistry, 281(44), 33433 - 33440.

Gales, L., Sousa, M. E., Pinto, M. M. M., & Damas, A. M. (2005). 3,4-Dihydroxy-9H-xanthen-9-one trihydrate. Acta Crystallographica Section E: Structure Reports Online, 61(7), o2213 - o2215.

Maia, F., Almeida, M. D. R., Gales, L., Kijjoa, A., et al. (2005). The binding of xanthone derivatives to transthyretin. Biochemical Pharmacology, 70(12), 1861 - 1869.

Gales, L., Macedo-Ribeiro, S., Arsequell, G., Valencia, G., et al. (2005). Human transthyretin in complex with iododiflunisal: Structural features associated with a potent amyloid inhibitor. Biochemical Journal, 388(2), 615 - 621.

Almeida, M. R., Gales, L., Damas, A. M., Cardoso, I., & Saraiva, M. J. (2005). Small transthyretin (TTR) ligands as possible therapeutic agents in TTR amyloidoses. Current Drug Targets: CNS and Neurological Disorders, 4(5), 587 - 596.

Gales, L., Cortes, L., Almeida, C., Melo, C. V., et al. (2005). Towards a structural understanding of the fibrillization pathway in Machado-Joseph's disease: Trapping early oligomers of non-expanded ataxin-3. Journal of Molecular Biology, 353(3), 642 - 654.

Gales, L., & Damas, A. M. (2005). Xanthones - A structural perspective. Current Medicinal Chemistry, 12(21), 2499 - 2515.

Neto-Silva, R. M., Macedo-Ribeiro, S., Pereira, P. J. B., Coll, M., et al. (2005). X-ray crystallographic studies of two transthyretin variants: Further insights into amyloidogenesis. Acta Crystallographica Section D: Biological Crystallography, 61(3), 333 - 339.

Vieira, L. M. M., Kijjoa, A., Wilairat, R., Nascimento, M. S. J., et al. (2004). Bioactive friedolanostanes and 11(10?8)-abeolanostanes from the bark of Garcinia speciosa. Journal of Natural Products, 67(12), 2043 - 2047.

Morais-De-Sá, E., Pereira, P. J. B., Saraiva, M. J., & Damas, A. M. (2004). The crystal structure of transthyretin in complex with diethylstilbestrol: A promising template for the design of amyloid inhibitors. Journal of Biological Chemistry, 279(51), 53483 - 53490.

Vieira, L. M. M., Kijjoa, A., Silva, A. M. S., Mondranondra, I. - O., et al. (2004). Lanostanes and friedolanostanes from the bark of Garcinia speciosa. Phytochemistry, 65(4), 393 - 398.